# Brazil signs agreement to expand immunoglobulin supplies

> The Hemobrás–Tiantan Bio cooperation covers supply of the plasma-derived medicine and prospective technology transfer.

- Canonical URL: https://newsverum.com/en/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026
- Publisher: Newsverum
- Section: Health
- Country: Brazil
- Published: 2026-10-06T17:11:49+00:00
- Updated: 2026-10-07T05:57:01+03:00
- Event / data period: 2026-10-02
- Other editions: [Türkçe](https://newsverum.com/tr/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026.md), [العربية](https://newsverum.com/ar/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026.md), [Français](https://newsverum.com/fr/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026.md), [Español](https://newsverum.com/es/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026.md), [Deutsch](https://newsverum.com/de/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026.md), [Português](https://newsverum.com/pt/news/brazil-hemobras-immunoglobulin-supply-agreement-october-2026.md)

Brazil’s Health Ministry said Hemobrás and China’s Tiantan Bio signed a cooperation agreement in São Paulo on October 2 to broaden immunoglobulin supply sources. The ministry said the agreement sets a framework for registration in Brazil, supply of intravenous human immunoglobulin, and technology licensing and transfer.

Supply and technology details will be defined in separate agreements and remain subject to Anvisa requirements. The ministry also said equipment upgrades are expected to raise plasma-storage capacity by about 30%, 604 pieces of equipment were distributed to 125 hemotherapy services, and 38 million reais was allocated to improve blood-center services.

## Data

### Blood-center investment and capacity

Outcomes and allocations stated in the Health Ministry’s October 2 notice.

Methodology: The approximate 30% is expected capacity; funding, equipment and service coverage are administrative totals reported by the ministry.

| label | value | unit | period | basis | value_qualifier |
|---|---|---|---|---|---|
| Capacity increase expected | 30.0 | % | 2026-10-02 | estimate | approximate |
| Blood-center service funding allocated | 38 | million BRL | 2026-10-02 | observed |  |
| Equipment distributed | 604 | count | 2026-10-02 | observed |  |
| Services receiving equipment | 125 | count | 2026-10-02 | observed |  |

Sources: <https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/> · Download data: [JSON](https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026/data/brazil-immunoglobulin-agreement-data?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/brazil-hemobras-immunoglobulin-supply-agreement-october-2026/data/brazil-immunoglobulin-agreement-data?lang=en&format=csv)

## Sources

- [Ministry of Health of Brazil](<https://www.gov.br/saude/pt-br/assuntos/noticias-ms/2026/outubro/brasil-firma-acordo-para-ampliar-producao-de-imunoglobulina-medicamento-para-doencas-do-sangue/>) (Source checked: 2026-10-06; Published: 2026-10-02)

## Correction history

- 2026-10-07T00:51:14+03:00: German and Portuguese editions and translations of the data and correction explanations have been added to this article.
- 2026-10-07T05:57:01+03:00: Data classification added: each figure now carries a measure identifier with its unit, geography, frequency and type. No figure, unit or date changed.

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)